This site is intended for healthcare professionals only
LoginRegister
New COVID-19 Vaccine gets FDA approvalNew COVID-19 Vaccine gets FDA approval
Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome CaseModerna receives USFDA nod for updated COVID vaccine
FDA Approves Updated mRNA Vaccines to Combat Emerging COVID-19 VariantsFDA Approves Updated mRNA Vaccines to Combat Emerging COVID-19 Variants
Low Vitamin D levels associated with low COVID-19 vaccine antibody titers among adultsLow Vitamin D levels associated with low COVID-19 vaccine antibody titers among adults
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic DermatitisPfizer, BioNTech gets USFDA nod for 2023-2024 COVID vaccine
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic DermatitisPfizer, Valneva report positive pediatric, adolescent phase 2 booster results for Lyme disease...
Daiichi Sankyo submits sNDA for Omicron XBB.1.5-adapted COVID vaccine in JapanDaiichi Sankyo submits sNDA for Omicron XBB.1.5-adapted COVID vaccine in Japan
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaEuropean Commission expands Merck Ervebo indication to include children 1 year of age and older
State-Wide Immunization Drive in Haryana Targets High-Risk AreasMpox vaccine effective in decreasing severity of monkeypox infection: The Lancet Infectious Diseases...
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic DermatitisPfizer-BioNTech updated COVID vaccine approved by UK regulator
Impact of COVID-19 vaccination on mortality after acute myocardial infarctionImpact of COVID-19 vaccination on mortality after acute myocardial infarction
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic DermatitisPfizer, BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID vaccine in EU
X